| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.07 |